Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McGill

Showing results (131-140 of 277) with videos related to

Pageof 28
Sort By:
Diabetes Care|September 11, 2020
Comparative Effectiveness of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney EventsYan Xie, Benjamin Bowe, Andrew K Gibson, et al.
Diabetes Care|October 4, 2012
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled studyJanet B McGill, Lance Sloan, Jennifer Newman, et al.
Gastroenterology|May 1, 1983
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic featuresP Kerlin, G L Davis, D B McGill, et al.
Diabetes Care|September 17, 2020
Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care DatabasesYan Xie, Benjamin Bowe, Andrew K Gibson, et al.
Digestive Diseases and Sciences|May 1, 1988
Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding. Appraisal of its clinical utilityM Goldschmiedt, D A Ahlquist, H S Wieand, et al.
The American Journal of the Medical Sciences|April 9, 2010
High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline dataBarry M Wall, Regina M Hardison, Mark E Molitch, et al.
Diabetologia|June 16, 2009
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label studyJ Rosenstock, V Fonseca, J B McGill, et al.
Journal of the American College of Cardiology|June 1, 1995
Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of Bayesian classifiersR F Wagner, K A Wear, J E Perez, et al.
BMJ Open Diabetes Research & Care|July 5, 2022
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuriaJanet B McGill, Hermann Haller, Prabir Roy-Chaudhury, et al.
Diabetes Technology & Therapeutics|March 5, 2024
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with SotagliflozinSchafer Boeder, Michael J Davies, Janet B McGill, et al.
Pageof 28

Showing results (131-140 of 277) with videos related to

Sort By:
Pageof 28
Diabetes Care|September 11, 2020
Comparative Effectiveness of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney EventsYan Xie, Benjamin Bowe, Andrew K Gibson, et al.
Diabetes Care|October 4, 2012
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled studyJanet B McGill, Lance Sloan, Jennifer Newman, et al.
Gastroenterology|May 1, 1983
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic featuresP Kerlin, G L Davis, D B McGill, et al.
Diabetes Care|September 17, 2020
Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care DatabasesYan Xie, Benjamin Bowe, Andrew K Gibson, et al.
Digestive Diseases and Sciences|May 1, 1988
Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding. Appraisal of its clinical utilityM Goldschmiedt, D A Ahlquist, H S Wieand, et al.
The American Journal of the Medical Sciences|April 9, 2010
High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline dataBarry M Wall, Regina M Hardison, Mark E Molitch, et al.
Diabetologia|June 16, 2009
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label studyJ Rosenstock, V Fonseca, J B McGill, et al.
Journal of the American College of Cardiology|June 1, 1995
Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of Bayesian classifiersR F Wagner, K A Wear, J E Perez, et al.
BMJ Open Diabetes Research & Care|July 5, 2022
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuriaJanet B McGill, Hermann Haller, Prabir Roy-Chaudhury, et al.
Diabetes Technology & Therapeutics|March 5, 2024
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with SotagliflozinSchafer Boeder, Michael J Davies, Janet B McGill, et al.
Pageof 28